VEGFA and breast carcinoma: Studies conducted on breast cancer cells MCF7 treated with miR-126 lipofectamine showed evident downregulation of VEGF-A, which is consistent with other studies and shows a negative correlation between upregulation of the VEGF-A expression level and downregulation of the miR-126 expression level.